Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 14, Number 9, 2008

Articles

An Introduction to the Structural Organization of Parasitic Protozoa
pp. 822-838(17)
Author: Souza, Wanderley d.

Favourites:
ADD
Favourites:
ADD

Kinetoplast as a Potential Chemotherapeutic Target of Trypanosomatids
pp. 847-854(8)
Author: Machado Motta, Maria C.

Favourites:
ADD

The Plastid-Like Organelle of Apicomplexan Parasites as Drug Target
pp. 855-871(17)
Authors: Wiesner, J.; Reichenberg, A.; Heinrich, S.; Schlitzer, M.; Jomaa, H.

Favourites:
ADD

The Hydrogenosome as a Drug Target
pp. 872-881(10)
Author: Benchimol, Marlene

Favourites:
ADD

The Acidocalcisome as a Target for Chemotherapeutic Agents in Protozoan Parasites
pp. 882-888(7)
Authors: Docampo, Roberto; Moreno, Silvia N.J.

Favourites:
ADD

Drugs Targeting Parasite Lysosomes
pp. 889-900(12)
Authors: Doyle, Patricia S.; Sajid, Mohamed; O'Brien, Theresa; DuBois, Kelly; Engel, Juan C.; Mackey, Zachary B.; Reed, Sharon

Favourites:
ADD

Fatty Acid Synthesis in Protozoan Parasites: Unusual Pathways and Novel Drug Targets
pp. 901-916(16)
Authors: Goodman, C. D.; McFadden, G. I.

Favourites:
ADD
Favourites:
ADD

Ultrastructural Alterations in Organelles of Parasitic Protozoa Induced by Different Classes of Metabolic Inhibitors
pp. 925-938(14)
Authors: Fernandes Rodrigues, Juliany C.; Souza, Wanderley de

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content